Edwards Lifesciences (NYSE:EW) Price-to-Operating-Cash-Flow

: 45.46 (As of Today)

View and export this data going back to 2000. Start your Free Trial

As of today (2023-09-30), Edwards Lifesciences's share price is $69.28. Edwards Lifesciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $1.52. Hence, Edwards Lifesciences's Price-to-Operating-Cash-Flow Ratio for today is 45.46.

The historical rank and industry rank for Edwards Lifesciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

EW' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.95 Med: 34.42 Max: 61.9
Current: 45.46

During the past 13 years, Edwards Lifesciences's highest Price-to-Operating-Cash-Flow Ratio was 61.90. The lowest was 7.95. And the median was 34.42.

EW's Price-to-Operating-Cash-Flow is ranked worse than
77.88% of 443 companies
in the Medical Devices & Instruments industry
Industry Median: 23.67 vs EW: 45.46

Edwards Lifesciences's Cash Flow from Operations per share for the three months ended in Jun. 2023 was $0.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $1.52.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Edwards Lifesciences was -37.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 1.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 13.90% per year.

During the past 13 years, Edwards Lifesciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 54.00% per year. The lowest was -13.30% per year. And the median was 15.80% per year.

Edwards Lifesciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Edwards Lifesciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

35.31

41.85

54.69

47.21

38.22

Edwards Lifesciences Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Price-to-Operating-Cash-Flow																39.15	39.67	38.22	41.39	61.90

Competitive Comparison

For the Medical Devices subindustry, Edwards Lifesciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Edwards Lifesciences Price-to-Operating-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Price-to-Operating-Cash-Flow falls in comparison to its industry or sector. The grey bar indicates the Price-to-Operating-Cash-Flow's extreme value range as defined by GuruFocus.

Edwards Lifesciences Price-to-Operating-Cash-Flow Calculation

Edwards Lifesciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	69.28	/	1.524
	=	45.46

Edwards Lifesciences's Share Price of today is $69.28.
Edwards Lifesciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.52.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Edwards Lifesciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (NYSE:EW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (NYSE:EW) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

EW:Mexico EWL:Germany E1WL34:Brazil EWLS:Austria

Address

One Edwards Way, Irvine, CA, USA, 92614

Website

https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Executives

Wayne Markowitz	officer: GM & SVP, Surgical	ONE EDWARDS WAY, IRVINE CA 92614
Paul A Laviolette	director	ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Ramona Sequeira	director	ONE EDWARDS WAY, IRVINE CA 92614
Daveen Chopra	officer: CVP, Surgical Structural Heart	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92618
Jean-luc M Lemercier	officer: CVP, EMEA, Canada, Latin Amer	C/O ONE EDWARDS WAY, IRVINE CA 92614
Scott B. Ullem	officer: CVP, CFO	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Bobo Donald E Jr	officer: CVP,Strategy/Corp Development	C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE CA 92614
Catherine M. Szyman	officer: CVP, Critical Care	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Sellers Robert W.a.	officer: VP, Corp. Controller (Principa	ONE EDWARDS WAY, IRVINE CA 92614
Heisz Leslie Stone	director	C/O PUBLIC STORAGE, 701 WESTERN AVENUE, GLENDALE CA 91201
Steven R Loranger	director	XYLEM. INC., 1133 WESTCHESTER AVENUE, WHITE PLAINS NY 10604
Bernard J Zovighian	officer: CVP, Surgical Heart Valves	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Martha H. Marsh	director	9769 WEXFORD CIRCLE, GRANITE BAY CA 95746
Kieran Gallahue	director	PO BOX 684369, PARK CITY UT 84068
Nicholas J Valeriani	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614